Puma Biotechnology, Inc. (NASDAQ:PBYI) Q2 2025 Earnings Call Transcript August 7, 2025 Puma Biotechnology, Inc. beats earnings expectations. Reported EPS is $0.15, expectations were $0.11 ...

Skillz Inc. (NYSE: SKLZ) Q2 2025 Earnings Call Transcript August 7, 2025 Skillz Inc. beats earnings expectations. Reported EPS is $-0.57574, expectations were $-1.34. Operator: Good afternoon all ...

Holley Inc. (NYSE:HLLY) Q2 2025 Earnings Call Transcript August 7, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the conference call to discuss Holley’s Second Quarter 2025 ...

Valens Semiconductor Ltd. (NYSE: VLN) Q2 2025 Earnings Call Transcript August 7, 2025 Operator: Good morning. My name is Yoni, and I will be your conference operator today. At this time, I would ...

Glucagon injection salesdeclined 25% to $20.6 million in Q2 2025, driven by increased competition and a market shift toward ready-to-use products. Epinephrine salesdecreased 42% to $16.2 million ...

Eli Lilly and Company (NYSE:LLY) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ETCompany ParticipantsDaniel M.

Acorn Energy develops and markets IoT-based remote monitoring solutions. Its subsidiary OmniMetrix provides hardware and cloud-based software that enable utilities, telecom, and industrial ...

Key PointsRevenue (GAAP) for Q2 2025 exceeded consensus expectations at $345.3 million, growing 11% over the prior-year period.

At Q2 2025 quarter-end, the pipeline included more than 800,000 square feet of leasing prospects at various stages, which may further influence future revenue and occupancy rates if closed by year ...

Datadog's Q2 revenue rose 28% year-over-year to $827 million, beating guidance and driven by strong growth from AI-native customers. Datadog launched 125+ new features, including AI observability ...

During Q2 2025, Sunrun registered a total revenue of US$569.3 million, up 9% from the same period a year ago. The increase in revenue came from customer agreements and incentives, which generated ...

Astera Labs, Inc. surpassed Q2 expectations with rapid growth in networking products, but high valuation prompts a Hold rating. Click for my ALAB stock update.